Health insurance claims data for treatment of gender dysphoria in children aged 6-17 years
![](https://static.wixstatic.com/media/7d0df7_dc391dfe4e1946d4b3b044259d893450~mv2.jpg/v1/fill/w_103,h_57,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/7d0df7_dc391dfe4e1946d4b3b044259d893450~mv2.jpg)
shows puberty blocker prescriptions have doubled since 2017, and claims for cross-sex hormones also doubled up until 2021. According to data compiled by Komodo Health Inc for Reuters in October, in 2021, 42,167 children and teens between the ages of 6 and 17 were diagnosed with gender dysphoria, three times the number in 2017. It's out of control.